Answers are grounded in this paper and cite their sources.
Fortification of a single meal with β-glucan-rich oyster mushroom (Pleurotus ostreatus) powder has been shown to increase the response of glucagon-like peptide 1 (GLP-1) and reduce concentrations of non-esterified fatty acids (NEFAs) in adults with impaired glucose tolerance (IGT). This secondary analysis of a randomized controlled crossover study (DRKS00015244) aimed to determine whether these effects are modulated by baseline gut microbiota composition. A fecal sample was collected once at baseline before consumption of either a P. ostreatus-enriched meal (EN) or a non-enriched meal (CON). The microbiota was analyzed using 16S rRNA V3-V4 sequencing. An inverse association was observed between alpha diversity and differences in the meal-induced GLP-1 response (p < 0.05), whereas NEFA responses appeared unaffected. Notably, only participants with lower microbial evenness showed a greater GLP-1 response after EN versus CON (p = 0.012). Additionally, the presence of Eubacterium ventriosum group and Clostridium methylpentosum group was associated with increased GLP-1 concentrations following EN (p < 0.05). Baseline gut microbiota composition modulates the GLP-1 response to a single meal fortified with β-glucan-rich oyster mushroom powder, with differences in GLP-1 response being more pronounced in individuals whose microbiome is more specialized in fermenting fiber into SCFAs.
No takes yet. Share an insight, caveat, or question.
Klümpen et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: